{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:11:49Z","timestamp":1793985109892,"version":"4.8.0"},"reference-count":64,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,4,9]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Arginase depletion with BCT-100 pegylated recombinant human arginase is cytotoxic to AML blasts.<\/jats:p>","DOI":"10.1182\/blood-2014-09-600643","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T08:28:18Z","timestamp":1424939298000},"page":"2386-2396","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":154,"title":["Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target"],"prefix":"10.1182","volume":"125","author":[{"given":"Francis","family":"Mussai","sequence":"first","affiliation":[{"name":"School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Egan","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine and Science, University of Nottingham, Nottingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Higginbotham-Jones","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Perry","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Beggs","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Odintsova","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Loke","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Pratt","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Pong","family":"U","sequence":"additional","affiliation":[{"name":"Bio-cancer Treatment International Ltd, Hong Kong Science Park, Shatin, New Territories, Hong Kong; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lo","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Kearns","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cheng","sequence":"additional","affiliation":[{"name":"Bio-cancer Treatment International Ltd, Hong Kong Science Park, Shatin, New Territories, Hong Kong; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"De Santo","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2019111817521484400_B1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1200\/JCO.2010.30.2554","article-title":"Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.","volume":"29","author":"Marcucci","year":"2011","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111817521484400_B2","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/sj.leu.2403924","article-title":"Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.","volume":"19","author":"Gibson","year":"2005","journal-title":"Leukemia"},{"issue":"11","key":"2019111817521484400_B3","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1073\/pnas.0409783102","article-title":"Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination.","volume":"102","author":"De Santo","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111817521484400_B4","doi-asserted-by":"crossref","first-page":"210454","DOI":"10.1155\/2012\/210454","article-title":"L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure.","volume":"2012","author":"Brenner","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"12","key":"2019111817521484400_B5","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1172\/JCI36264","article-title":"Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.","volume":"118","author":"De Santo","year":"2008","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111817521484400_B6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.semcancer.2005.04.002","article-title":"Arginine deprivation and metabolomics: important aspects of intermediary metabolism in relation to the differential sensitivity of normal and tumour cells.","volume":"15","author":"Wheatley","year":"2005","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2019111817521484400_B7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","article-title":"Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.","volume":"67","author":"Cheng","year":"2007","journal-title":"Cancer Res"},{"key":"2019111817521484400_B8","article-title":"Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma [published online ahead of print February 10, 2015].","author":"Yau","journal-title":"Invest New Drugs"},{"issue":"2","key":"2019111817521484400_B9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1755-148X.2010.00798.x","article-title":"Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.","volume":"24","author":"Lam","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"2019111817521484400_B10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-8722-5-17","article-title":"Deprivation of arginine by recombinant human arginase in prostate cancer cells.","volume":"5","author":"Hsueh","year":"2012","journal-title":"J Hematol Oncol"},{"issue":"5","key":"2019111817521484400_B11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2013-01-480129","article-title":"Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.","volume":"122","author":"Mussai","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2019111817521484400_B12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1006\/jmcc.1998.0655","article-title":"The statistics of synergism.","volume":"30","author":"Slinker","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"2019111817521484400_B13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.","volume":"22","author":"Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"issue":"6 suppl 2","key":"2019111817521484400_B14","doi-asserted-by":"crossref","first-page":"1602S","DOI":"10.1093\/jn\/137.6.1602S","article-title":"Arginine metabolism: boundaries of our knowledge.","volume":"137","author":"Morris","year":"2007","journal-title":"J Nutr"},{"issue":"6","key":"2019111817521484400_B15","first-page":"E473","article-title":"Source and fate of circulating citrulline.","volume":"241","author":"Windmueller","year":"1981","journal-title":"Am J Physiol"},{"issue":"2","key":"2019111817521484400_B16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1432-1033.1985.tb09196.x","article-title":"Expression of nuclear genes encoding the urea cycle enzymes, carbamoyl-phosphate synthetase I and ornithine carbamoyl transferase, in rat liver and intestinal mucosa.","volume":"152","author":"Ryall","year":"1985","journal-title":"Eur J Biochem"},{"issue":"6 Pt 2","key":"2019111817521484400_B17","first-page":"F916","article-title":"Localization of arginine synthesis along rat nephron.","volume":"259","author":"Levillain","year":"1990","journal-title":"Am J Physiol"},{"issue":"suppl 10","key":"2019111817521484400_B18","doi-asserted-by":"crossref","first-page":"2752S","DOI":"10.1093\/jn\/134.10.2752S","article-title":"Plasma membrane transporters for arginine.","volume":"134","author":"Closs","year":"2004","journal-title":"J Nutr"},{"issue":"5","key":"2019111817521484400_B19","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1073\/pnas.78.5.3235","article-title":"Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.","volume":"78","author":"Major","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"2019111817521484400_B20","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/0006-2952(82)90266-0","article-title":"Effect of ARA-C incorporation on deoxyribonucleic acid synthesis in cells.","volume":"31","author":"Major","year":"1982","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2019111817521484400_B21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ajh.23655","article-title":"Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy.","volume":"89","author":"Jabbour","year":"2014","journal-title":"Am J Hematol"},{"issue":"1","key":"2019111817521484400_B22","doi-asserted-by":"crossref","first-page":"e87475","DOI":"10.1371\/journal.pone.0087475","article-title":"Sequential treatment with cytarabine and decitabine has an increased anti-leukemia effect compared to cytarabine alone in xenograft models of childhood acute myeloid leukemia.","volume":"9","author":"Leonard","year":"2014","journal-title":"PLoS ONE"},{"key":"2019111817521484400_B23","first-page":"124","article-title":"Morphological features of cell death.","volume":"19","author":"Ziegler","year":"2004","journal-title":"News Physiol Sci"},{"issue":"9","key":"2019111817521484400_B24","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1182\/blood.V95.9.2897.009k14_2897_2904","article-title":"P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway.","volume":"95","author":"Pallis","year":"2000","journal-title":"Blood"},{"key":"2019111817521484400_B25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis.","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol"},{"issue":"20","key":"2019111817521484400_B26","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2013-03-493163","article-title":"Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.","volume":"122","author":"Willems","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2019111817521484400_B27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nbt.2285","article-title":"Therapeutic targets in cancer cell metabolism and autophagy.","volume":"30","author":"Cheong","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2019111817521484400_B28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00418-007-0356-9","article-title":"Morphological and cytochemical determination of cell death by apoptosis.","volume":"129","author":"Taatjes","year":"2008","journal-title":"Histochem Cell Biol"},{"issue":"9","key":"2019111817521484400_B29","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4161\/auto.7.9.15760","article-title":"Seeing is believing: the impact of electron microscopy on autophagy research.","volume":"7","author":"Eskelinen","year":"2011","journal-title":"Autophagy"},{"issue":"8","key":"2019111817521484400_B30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.freeradbiomed.2009.02.001","article-title":"Dependence of leukemic cell proliferation and survival on H2O2 and L-arginine.","volume":"46","author":"Brown","year":"2009","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"2019111817521484400_B31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1189\/jlb.3AB0214-082R","article-title":"Granulocyte functions are independent of arginine availability.","volume":"96","author":"Kapp","year":"2014","journal-title":"J Leukoc Biol"},{"issue":"6","key":"2019111817521484400_B32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/CJI.0b013e31825be926","article-title":"Interaction between invariant NKT cells and myeloid-derived suppressor cells in cancer patients: evidence and therapeutic opportunities.","volume":"35","author":"Mussai","year":"2012","journal-title":"J Immunother"},{"issue":"3","key":"2019111817521484400_B33","first-page":"1100","article-title":"Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity.","volume":"61","author":"Chang","year":"2001","journal-title":"Cancer Res"},{"issue":"2-3","key":"2019111817521484400_B34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","article-title":"The SLC3 and SLC7 families of amino acid transporters.","volume":"34","author":"Fotiadis","year":"2013","journal-title":"Mol Aspects Med"},{"issue":"2","key":"2019111817521484400_B35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1189\/jlb.0910510","article-title":"Arginine transport in human monocytic leukemia THP-1 cells during macrophage differentiation.","volume":"90","author":"Barilli","year":"2011","journal-title":"J Leukoc Biol"},{"issue":"4","key":"2019111817521484400_B36","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood-2005-08-3166","article-title":"L-arginine import via cationic amino acid transporter CAT1 is essential for both differentiation and proliferation of erythrocytes.","volume":"107","author":"Shima","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2019111817521484400_B37","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jnutbio.2004.03.005","article-title":"Biochemical responses of healthy subjects during dietary supplementation with L-arginine.","volume":"15","author":"Evans","year":"2004","journal-title":"J Nutr Biochem"},{"issue":"Pt 1","key":"2019111817521484400_B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: nitric oxide and beyond.","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem J"},{"issue":"4","key":"2019111817521484400_B39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0301-0082(00)00056-3","article-title":"Arginine metabolism and the synthesis of nitric oxide in the nervous system.","volume":"64","author":"Wiesinger","year":"2001","journal-title":"Prog Neurobiol"},{"issue":"4","key":"2019111817521484400_B40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI30235","article-title":"Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.","volume":"117","author":"Iwamoto","year":"2007","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111817521484400_B41","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-12-2641","article-title":"ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance.","volume":"19","author":"Huang","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2019111817521484400_B42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s13277-013-1020-8","article-title":"Deficiency in expression and epigenetic DNA methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance.","volume":"35","author":"Lan","year":"2014","journal-title":"Tumour Biol"},{"issue":"10","key":"2019111817521484400_B43","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1007\/s11033-013-2691-3","article-title":"Plasma-free amino acid profiling of cervical cancer and cervical intraepithelial neoplasia patients and its application for early detection.","volume":"40","author":"Hasim","year":"2013","journal-title":"Mol Biol Rep"},{"issue":"4","key":"2019111817521484400_B44","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","article-title":"Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.","volume":"69","author":"Rodriguez","year":"2009","journal-title":"Cancer Res"},{"issue":"31","key":"2019111817521484400_B45","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.2174\/092986712803833290","article-title":"The role of a disturbed arginine\/NO metabolism in the onset of cancer cachexia: a working hypothesis.","volume":"19","author":"Buijs","year":"2012","journal-title":"Curr Med Chem"},{"issue":"12","key":"2019111817521484400_B46","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1021\/mp300190g","article-title":"Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration.","volume":"9","author":"Zhan","year":"2012","journal-title":"Mol Pharm"},{"issue":"25","key":"2019111817521484400_B47","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1182\/blood-2009-12-258822","article-title":"Pegylated arginase I: a potential therapeutic approach in T-ALL.","volume":"115","author":"Hernandez","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111817521484400_B48","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjc.6600681","article-title":"Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures.","volume":"88","author":"Philip","year":"2003","journal-title":"Br J Cancer"},{"issue":"6","key":"2019111817521484400_B49","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1054\/bjoc.2000.1353","article-title":"Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells.","volume":"83","author":"Scott","year":"2000","journal-title":"Br J Cancer"},{"issue":"1","key":"2019111817521484400_B50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2006.06.001","article-title":"Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis.","volume":"10","author":"Degenhardt","year":"2006","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111817521484400_B51","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2008.11.031","article-title":"Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest.","volume":"277","author":"Lam","year":"2009","journal-title":"Cancer Lett"},{"issue":"3","key":"2019111817521484400_B52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/leu.2012.247","article-title":"Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia.","volume":"27","author":"Morrow","year":"2013","journal-title":"Leukemia"},{"key":"2019111817521484400_B53","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1038\/cddis.2013.359","article-title":"Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin\u2019s lymphoma cells.","volume":"4","author":"Zeng","year":"2013","journal-title":"Cell Death Dis"},{"issue":"3","key":"2019111817521484400_B54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.leukres.2013.12.021","article-title":"miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia.","volume":"38","author":"Ufkin","year":"2014","journal-title":"Leuk Res"},{"key":"2019111817521484400_B55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semcdb.2014.03.005","article-title":"Epiregulin: roles in normal physiology and cancer.","volume":"28","author":"Riese","year":"2014","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"2019111817521484400_B56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2141.2008.07053.x","article-title":"Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.","volume":"141","author":"Al Shaer","year":"2008","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111817521484400_B57","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.leukres.2013.10.026","article-title":"A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia.","volume":"38","author":"Deangelo","year":"2014","journal-title":"Leuk Res"},{"issue":"4","key":"2019111817521484400_B58","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/leu.2009.292","article-title":"Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia.","volume":"24","author":"Lancet","year":"2010","journal-title":"Leukemia"},{"issue":"5","key":"2019111817521484400_B59","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2141.2010.08470.x","article-title":"Acute myeloid leukaemia in the elderly: a review.","volume":"152","author":"Pollyea","year":"2011","journal-title":"Br J Haematol"},{"issue":"27","key":"2019111817521484400_B60","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1200\/JCO.2006.06.5037","article-title":"Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.","volume":"24","author":"Creutzig","year":"2006","journal-title":"J Clin Oncol"},{"issue":"13","key":"2019111817521484400_B61","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1200\/JCO.2009.26.7765","article-title":"Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.","volume":"28","author":"Glazer","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111817521484400_B62","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/hep.22474","article-title":"Ammonia impairs neutrophil phagocytic function in liver disease.","volume":"48","author":"Shawcross","year":"2008","journal-title":"Hepatology"},{"issue":"11","key":"2019111817521484400_B63","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1517\/13543784.2014.934808","article-title":"The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on phase I\/II clinical trials.","volume":"23","author":"Synakiewicz","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"2019111817521484400_B64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1634\/theoncologist.12-8-991","article-title":"FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).","volume":"12","author":"Dinndorf","year":"2007","journal-title":"Oncologist"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/15\/2386\/1384473\/2386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/15\/2386\/1384473\/2386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T22:52:47Z","timestamp":1574117567000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/125\/15\/2386\/33839\/Arginine-dependence-of-acute-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":64,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2015,4,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-09-600643","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]}}}